Literature DB >> 21078447

Viral sequence analysis from HIV-infected mothers and infants: molecular evolution, diversity, and risk factors for mother-to-child transmission.

Philip L Bulterys1, Sudeb C Dalai, David A Katzenstein.   

Abstract

Great progress has been made in understanding the pathogenesis, treatment, and transmission of HIV and the factors influencing the risk of mother-to-child transmission (MTCT). Many questions regarding the molecular evolution and genetic diversity of HIV in the context of MTCT remain unanswered. Further research to identify the selective factors governing which variants are transmitted, how the compartmentalization of HIV in different cells and tissues contributes to transmission, and the influence of host immunity, viral diversity, and recombination on MTCT may provide insight into new prevention strategies and the development of an effective HIV vaccine.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21078447      PMCID： PMC3175486          DOI： 10.1016/j.clp.2010.08.003

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN： 0095-5108            Impact factor:   3.430


  109 in total

1.  Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group.

Authors:  N Shaffer; R Chuachoowong; P A Mock; C Bhadrakom; W Siriwasin; N L Young; T Chotpitayasunondh; S Chearskul; A Roongpisuthipong; P Chinayon; J Karon; T D Mastro; R J Simonds
Journal:  Lancet       Date:  1999-03-06       Impact factor: 79.321

2.  Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women.

Authors:  Sherene S Min; Amanda H Corbett; Naser Rezk; Susan Cu-Uvin; Susan A Fiscus; Leslie Petch; Myron S Cohen; Angela D M Kashuba
Journal:  J Acquir Immune Defic Syndr       Date:  2004-12-15       Impact factor: 3.731

3.  HIV-1 populations in blood and breast milk are similar.

Authors:  Gavin J Henderson; Noah G Hoffman; Li Hua Ping; Susan A Fiscus; Irving F Hoffman; Kathryn M Kitrinos; Topia Banda; Francis E A Martinson; Peter N Kazembe; David A Chilongozi; Myron S Cohen; Ronald Swanstrom
Journal:  Virology       Date:  2004-12-05       Impact factor: 3.616

4.  6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mère-Enfant.

Authors:  F Dabis; P Msellati; N Meda; C Welffens-Ekra; B You; O Manigart; V Leroy; A Simonon; M Cartoux; P Combe; A Ouangré; R Ramon; O Ky-Zerbo; C Montcho; R Salamon; C Rouzioux; P Van de Perre; L Mandelbrot
Journal:  Lancet       Date:  1999-03-06       Impact factor: 79.321

5.  Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial.

Authors:  S Z Wiktor; E Ekpini; J M Karon; J Nkengasong; C Maurice; S T Severin; T H Roels; M K Kouassi; E M Lackritz; I M Coulibaly; A E Greenberg
Journal:  Lancet       Date:  1999-03-06       Impact factor: 79.321

6.  Human immunodeficiency virus type 1 genomic RNA sequences in the female genital tract and blood: compartmentalization and intrapatient recombination.

Authors:  Sean Philpott; Harold Burger; Christos Tsoukas; Brian Foley; Kathryn Anastos; Christina Kitchen; Barbara Weiser
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

7.  Compartmentalization of the IgG immune response to HIV-1 in breast milk.

Authors:  P Becquart; H Hocini; B Garin; A Sépou; M D Kazatchkine; L Bélec
Journal:  AIDS       Date:  1999-07-30       Impact factor: 4.177

8.  Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.

Authors:  P M Garcia; L A Kalish; J Pitt; H Minkoff; T C Quinn; S K Burchett; J Kornegay; B Jackson; J Moye; C Hanson; C Zorrilla; J F Lew
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

9.  Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.

Authors:  L A Guay; P Musoke; T Fleming; D Bagenda; M Allen; C Nakabiito; J Sherman; P Bakaki; C Ducar; M Deseyve; L Emel; M Mirochnick; M G Fowler; L Mofenson; P Miotti; K Dransfield; D Bray; F Mmiro; J B Jackson
Journal:  Lancet       Date:  1999-09-04       Impact factor: 79.321

10.  Mosaic structure of the human immunodeficiency virus type 1 genome infecting lymphoid cells and the brain: evidence for frequent in vivo recombination events in the evolution of regional populations.

Authors:  A Morris; M Marsden; K Halcrow; E S Hughes; R P Brettle; J E Bell; P Simmonds
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103
View more
  5 in total

1.  Perspectives on the role of patient-centered medical homes in HIV Care.

Authors:  Gregory Pappas; Jia Yujiang; Naomi Seiler; Mary-Beth Malcarney; Katherine Horton; Irshad Shaikh; Gunther Freehill; Carla Alexander; Mohammad N Akhter; Julia Hidalgo
Journal:  Am J Public Health       Date:  2014-05-15       Impact factor: 9.308

Review 2.  The role of HIV replicative fitness in perinatal transmission of HIV.

Authors:  Xue-Qing Chen; Chang Liu; Xiao-Hong Kong
Journal:  Virol Sin       Date:  2011-06-12       Impact factor: 4.327

3.  Single-Chain Variable Fragments of Broadly Neutralizing Antibodies Prevent HIV Cell-Cell Transmission.

Authors:  Rebecca T van Dorsten; Lucia Reh; Alexandra Trkola; Lynn Morris; Penny L Moore
Journal:  J Virol       Date:  2021-12-22       Impact factor: 6.549

4.  The Role of Patient Navigators in Building a Medical Home for Multiply Diagnosed HIV-Positive Homeless Populations.

Authors:  Mariana Sarango; Alexander de Groot; Melissa Hirschi; Chukwuemeka Anthony Umeh; Serena Rajabiun
Journal:  J Public Health Manag Pract       Date:  2017 May/Jun

5.  Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma.

Authors:  Amit Kumar; Claire E P Smith; Elena E Giorgi; Joshua Eudailey; David R Martinez; Karina Yusim; Ayooluwa O Douglas; Lisa Stamper; Erin McGuire; Celia C LaBranche; David C Montefiori; Genevieve G Fouda; Feng Gao; Sallie R Permar
Journal:  PLoS Pathog       Date:  2018-04-19       Impact factor: 6.823
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.